Global Thebaine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.

Scope of the Report:
Currently, because of the special properties of thebaine, subject to strict control in most countries, so the market production control by the country's policy.
Thebaine production industry is a highly profitable industry. In the United States and other regions, more and more enterprises begin to apply to enter this field, but the current situation, the market is still controlled by the Mallinckrodt Pharmaceuticals and Noramco.
But as the downstream drugs market gradually matures, the next few years, thebaine and his relevant market will gradually popular, so the next few years, thebaine have a certain degree of price rise, but the rate should be minimal
The worldwide market for Thebaine is expected to grow at a CAGR of roughly 1.1% over the next five years, will reach 1240 million US$ in 2024, from 1160 million US$ in 2019, according to a new study.
This report focuses on the Thebaine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Mallinckrodt Pharmaceuticals
Noramco
Alcaliber
Tasmanian Alkaloids
TPI
Cepia-Sanofi
Taj Pharmaceuticals
API Labs
Faran Shimi Pharmaceuticals
Gansu Alkaloids
Hwells

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Food Grade
Pharmaceutical Grade

Market Segment by Applications, can be divided into
Oxymorphone
Nalbuphine
Naltrexone
Buprenorphine
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Thebaine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Thebaine, with price, sales, revenue and global market share of Thebaine in 2017 and 2018.
Chapter 3, the Thebaine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Thebaine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Thebaine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Thebaine sales channel, distributors, customers, research findings and conclusion, appendix and data source.